Aetna Inc. v. AstraZeneca LP et al
Aetna Inc. |
AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and Handa Pharmaceuticals, LLC |
3:2023cv00764 |
February 21, 2023 |
US District Court for the Northern District of California |
Joseph C Spero |
Anti-Trust |
28 U.S.C. ยง 1332 Diversity-(Citizenship) |
None |
Docket Report
This docket was last retrieved on February 23, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 6 NOTICE of Voluntary Dismissal Without Prejudice by Aetna Inc. (Weiler, Matthew) (Filed on 2/23/2023) |
Filing 5 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 5/19/2023. Initial Case Management Conference set for 5/26/2023 02:00 PM in San Francisco, Courtroom F, 15th Floor. (cv, COURT STAFF) (Filed on 2/21/2023) |
Filing 4 Case assigned to Magistrate Judge Joseph C. Spero. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening.Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 3/7/2023. (cv, COURT STAFF) (Filed on 2/21/2023) |
Filing 3 Certificate of Interested Entities by AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited (Strotz, Peter) (Filed on 2/21/2023) |
Filing 2 Rule 7.1 Disclosures by AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Strotz, Peter) (Filed on 2/21/2023) |
Filing 1 NOTICE OF REMOVAL from San Francisco Superior Court. Their case number is not assigned. (Filing fee $402 receipt number ACANDC-18007101). Filed byAstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca LP. (Attachments: #1 Exhibit A - State Court Complaint, #2 Exhibit B - AstraZeneca Defendants Disclosure Statement, #3 Civil Cover Sheet)(Strotz, Peter) (Filed on 2/21/2023) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.